Processa Pharmaceuticals

Processa Pharmaceuticals is committed to improving the quality of life for patients with unmet medical needs.
#NASDAQ: $PCSA

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference $PCSA

https://t.co/z91VGTfZjP

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research $PCSA

https://t.co/JLpe1dLm19

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial $PCSA

https://t.co/jQAir9IPTj

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals to Present Data at the American Association for #Cancer Research Annual Meeting $PCSA

David Young, PharmD, Ph.D., President of Research at Processa, will be available during for meetings along with Processa CEO George Ng.

https://t.co/L7HhoYHMs2

[Processa Pharmaceuticals @processanews]

#ICYMI Processa Pharma, CEO, George Ng Talks Next Gen Treatment For #Cancer & Other Chronic Diseases with @adamsarhan $PCSA

https://t.co/cylXRbPvy8

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference $PCSA

2024 BIO CEO & Investor Conference being held on February 26 – 27, 2024 at the Marriott Marquis in New York City.

Investors can register for the conference

here: https://t.co/ny0Cmesx3K

[Processa Pharmaceuticals @processanews]

Our CEO George Ng will be presenting at the BIO CEO & Investor Conference on February 26th. For a meeting, please send us an email per the below. $PCSA #cancer #oncology #chemotherapy

[Processa Pharmaceuticals @processanews]

$PCSA

https://t.co/xbmHw5InJO

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced #Cancer Resulting in Recommended Phase 2 Doses $PCSA

https://t.co/gtL9yqaAkm

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

#cancer #chemotherapy $PCSA

https://t.co/sDgPdfXj7G

[Processa Pharmaceuticals @processanews]

At JPM, biotech's most prolific deal maker sees a rosy 2024 for acquisitions. $PCSA

https://t.co/R67DU8UioA

[Processa Pharmaceuticals @processanews]

George Ng, Chief Executive Officer, will present a corporate overview at the Biotech Showcase
The event is being held at the Hilton San Francisco Union Square on January 8 – 10, 2024. $PCSA

January 8, 2024
Time: 4:00pm PST (Yosemite Room A)
Webcast Link: https://t.co/PVFgvmbAK3

[Processa Pharmaceuticals @processanews]

https://t.co/W6ezxiZqfV

[Processa Pharmaceuticals @processanews]

We'll be at the J.P. Morgan Healthcare Conference. We'd love to see you while there. Please email us per the below for a meeting. $PCSA

[Processa Pharmaceuticals @processanews]

@AudieCornish, recently heard from listeners on Drug Shortages and Ageism, and the shortage of #chemotherapy drugs.

Processa is focused on developing the Next Generation Chemotherapy drugs to improve the safety and efficacy of cancer treatment. 

https://t.co/VtMbLKXHBA

[Processa Pharmaceuticals @processanews]

We will be at the J.P. Morgan Healthcare Conference in SF in January, and we are excited to connect with you. Meet our CEO George Ng to learn more about how we are developing the Next Generation Chemotherapy (NGC) drugs to improve the safety and efficacy of #cancer treatment.

[Processa Pharmaceuticals @processanews]

The Company will conduct a Fireside Chat today at 4:30PM ET to discuss recent data in further detail and lay out the Company’s corporate strategy with regard to the NGC platform. Investors interested in listening may register early for the event at:

https://t.co/1Pv35YIkP0

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine #Cancer #chemotherapy $PCSA

https://t.co/gfQOAWfqzq

[Processa Pharmaceuticals @processanews]

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine #chemotherapy #oncology #cancer $PCSA

https://t.co/XAFc6cmzAp

[Processa Pharmaceuticals @processanews]

Please find a letter to shareholders from our CEO George Ng.

#cancer #oncology #chemotherapy $PCSA

https://t.co/rWUXoeDjoX